BioRestorative Therapies (BRTX) News Today $1.80 -0.16 (-8.16%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period BioRestorative Therapies- BRTX-100 program receives FDA Fast Track designationFebruary 20 at 12:26 PM | markets.businessinsider.comBRTX-100 Front and Center at ORS 2025February 10, 2025 | markets.businessinsider.comBioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025February 10, 2025 | markets.businessinsider.comPleasing Signs As A Number Of Insiders Buy BioRestorative Therapies StockDecember 26, 2024 | uk.finance.yahoo.comRoth MKM Remains a Buy on BioRestorative Therapies (BRTX)November 16, 2024 | markets.businessinsider.comBioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease ProgramOctober 31, 2024 | markets.businessinsider.comBRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024August 13, 2024 | markets.businessinsider.comBioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 13, 2024 | finance.yahoo.comStrong Buy Rating for BioRestorative Therapies Amidst Strategic Partnerships and Innovative Clinical ProgressMay 18, 2024 | markets.businessinsider.comOptimistic Outlook for BioRestorative Therapies Backed by Clinical and Strategic AdvancesApril 19, 2024 | markets.businessinsider.comBioRestorative Therapies (BRTX) Price Target Decreased by 16.00% to 10.71April 17, 2024 | msn.com10 Micro-Cap Healthcare Stocks Insiders Are BuyingApril 14, 2024 | finance.yahoo.comBioRestorative Therapies Inc (BRTX)February 16, 2024 | investing.comBioRestorative Therapies, Inc.: BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society 2024 Annual MeetingFebruary 14, 2024 | finanznachrichten.dePRSO, AKRO and MIRA among pre-market losersFebruary 6, 2024 | msn.comGut Health Could Play A Role In How Blood Cancer Patients Respond To New TherapiesDecember 20, 2023 | forbes.comBioRestorative Therapies Shares Rise 14% on Allowance for Patent ApplicationDecember 12, 2023 | marketwatch.comBioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramDecember 12, 2023 | finance.yahoo.comBest Light Therapy Lamps for 2023November 9, 2023 | cnet.comBioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York CityOctober 9, 2023 | finance.yahoo.comBioRestorative Therapies' 10% shareholder Broadrick Dale increases holdingSeptember 18, 2023 | seekingalpha.comRoth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says “Low Valuation Undeserved”September 18, 2023 | finance.yahoo.comBioRestorative Therapies, Inc: BioRestorative Therapies Enters into Supply Agreement with Evolutionary BiologicsSeptember 12, 2023 | finanznachrichten.deBioRestorative Therapies Enters into Supply Agreement with Evolutionary BiologicsSeptember 12, 2023 | stockhouse.comBioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc DiseaseSeptember 8, 2023 | finance.yahoo.com$BRTX Is Looking To Treat Chronic Pain Without The Need For Class-A DrugsAugust 30, 2023 | msn.comAs America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A DrugsAugust 29, 2023 | benzinga.comRoth MKM Reiterates BioRestorative Therapies (BRTX) Buy RecommendationAugust 15, 2023 | msn.comMirati (MRTX) Reports Q2 Loss, Misses Revenue EstimatesAugust 8, 2023 | finance.yahoo.com$BRTX: Insights From A Specialist On Stem Cell-Based Therapies And The Need For Spinal Care ReformJuly 27, 2023 | msn.comInsider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX)July 27, 2023 | finance.yahoo.comBioRestorative Therapies, Inc.: BioRestorative Therapies Receives Landmark License From New York StateJuly 21, 2023 | finanznachrichten.deBioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York StateJuly 21, 2023 | finance.yahoo.com$BRTX's Drug Candidate BRTX-100 Excels In Safety Test, Advances To Phase 2 And Expands PipelineJuly 18, 2023 | msn.comWhy BioRestorative Therapies (BRTX) Stock Is Getting HammeredJuly 11, 2023 | msn.comBioRestorative Therapies Announces $2.1 Million Registered Direct OfferingJuly 11, 2023 | finance.yahoo.comBioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline OpportunitiesJuly 7, 2023 | finance.yahoo.comEXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease To Continue UnchangedJune 27, 2023 | benzinga.comBioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any ChangesJune 27, 2023 | finance.yahoo.comEXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease Study To Continue UnchangedJune 27, 2023 | finance.yahoo.comBioResorative CEO is Featured in An Interview With SmallCaps DailyJune 26, 2023 | finance.yahoo.comIs BioRestorative Therapies (NASDAQ:BRTX) In A Good Position To Invest In Growth?June 17, 2023 | finance.yahoo.comBioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ETJune 16, 2023 | finance.yahoo.comBioRestorative Therapies, Inc.: Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight ItJune 15, 2023 | finanznachrichten.deMetabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight ItJune 15, 2023 | finance.yahoo.comBioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare ConferenceJune 1, 2023 | finance.yahoo.comBioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell ProcessingMay 31, 2023 | finance.yahoo.comA New Era In Regenerative Medicine? BioRestorative Therapies (NASDAQ:BRTX) Reports Leading The Expansion Of The Adipose-Derived Stem Cell Therapy MarketMay 12, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and BioRestorative Therapies (BRTX)May 9, 2023 | markets.businessinsider.comEXCLUSIVE: BioRestorative Therapies & Northwell Health Ink Trial Pact For Chronic Lower Back Pain StudyMay 8, 2023 | msn.com Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BRTX Media Mentions By Week BRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BRTX News Sentiment▼1.000.60▲Average Medical News Sentiment BRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BRTX Articles This Week▼10▲BRTX Articles Average Week Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies True Nature News Today Enzo Biochem News Today NewGenIvf Group News Today Concord Medical Services News Today American Shared Hospital Services News Today Kindly MD News Today Marpai News Today Mangoceuticals News Today OpGen News Today Pacific Health Care Organization News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BRTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.